Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
SELLAS Life Sciences' value hinges on the pivotal REGAL phase 3 trial in AML, with interim results showing promise, but final outcomes still unknown. Despite encouraging data, I remain highly cautious ...
NEW YORK--(BUSINESS WIRE)--Builds Bio+, the premier life science membership organization that connects all segments of the life sciences ecosystem across major regional clusters, today announced the ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Over the past 150 years, humanity has unleashed unimaginable energy by splitting ...
Anthropic announced Claude for Life Sciences, an AI integration for researchers to advance scientific discovery. Claude for Life Sciences is built around Anthropic's existing AI models and supports ...
The Board on Life Sciences (BLS) was established in 1984 to serve as the focal point for addressing critical, emerging policy and technical issues associated with the life sciences and biotechnology ...
This activity was supported by the National Academy of Sciences and the U.S. Department of Defense and the Army Research Office (Contract No. W911NF-23-D-0002). Any opinions, findings, conclusions, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results